Guided Therapeutics GTHP
OTC GTHP
$0.25 +0.05 (+25.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Guided Therapeutics (GTHP) Cash from Financing Activities (2011 - 2026)

Updated

Guided Therapeutics (GTHP) posted Cash from Financing Activities of -$38,000 for Q2 2026, compared with $239,000 a year earlier.

Analysis

Guided Therapeutics (GTHP) Cash from Financing Activities (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Guided Therapeutics was $1.33 million, up 9.7% year-over-year; for FY2025, it was $745,000, down 18.7% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -8.5% (FY2020 to FY2025).
  • In prior years, Guided Therapeutics' Cash from Financing Activities was $916,000 in FY2024, $24,000 in FY2023 (-99.2%), $3.18 million in FY2022 (+53.8%) and $2.07 million in FY2021 (+78.3%).
  • The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities since Q1 2024.
  • On a year-over-year basis, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 127.1%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2022, with growth of 687.9%; the weakest was Q1 2023, with a decline of 91.6%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $923,000 (Q1 2026), $267,000 (Q4 2025) and $181,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -1.57 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -3.52 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.27 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -287.90 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -343.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -95.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -410.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -300,000.00
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -577.00 Mn
10 Guided Therapeutics 24.13 Mn 23.60 Mn - -38,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38,000.00
Mar 31, 2026 923,000.00
Dec 31, 2025 267,000.00
Sep 30, 2025 181,000.00
Jun 30, 2025 239,000.00
Mar 31, 2025 58,000.00
Dec 31, 2024 526,000.00
Sep 30, 2024 392,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 -46,000.00
Dec 31, 2023 196,000.00
Sep 30, 2023 -154,000.00
Jun 30, 2023 -41,000.00
Mar 31, 2023 23,000.00
Dec 31, 2022 -42,000.00
Sep 30, 2022 2.86 Mn
Jun 30, 2022 87,000.00
Mar 31, 2022 275,000.00
Dec 31, 2021 -53,000.00
Sep 30, 2021 363,000.00
API Access

Guided Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GTHP&period=max&api_key=YOUR_API_KEY